TWI642446B - 包含氧化鋅和檸檬酸鋅之潔牙劑組成物 - Google Patents
包含氧化鋅和檸檬酸鋅之潔牙劑組成物 Download PDFInfo
- Publication number
- TWI642446B TWI642446B TW103143993A TW103143993A TWI642446B TW I642446 B TWI642446 B TW I642446B TW 103143993 A TW103143993 A TW 103143993A TW 103143993 A TW103143993 A TW 103143993A TW I642446 B TWI642446 B TW I642446B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- fluoride
- sodium
- weight
- patent application
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 122
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 title claims abstract description 46
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 title claims abstract description 26
- 239000011746 zinc citrate Substances 0.000 title claims abstract description 26
- 235000006076 zinc citrate Nutrition 0.000 title claims abstract description 26
- 229940068475 zinc citrate Drugs 0.000 title claims abstract description 26
- 239000011787 zinc oxide Substances 0.000 title claims abstract description 23
- 239000000551 dentifrice Substances 0.000 title claims description 17
- -1 sodium fluorosilicate Chemical compound 0.000 claims description 39
- 210000000214 mouth Anatomy 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 208000025157 Oral disease Diseases 0.000 claims description 4
- 208000030194 mouth disease Diseases 0.000 claims description 4
- 239000000606 toothpaste Substances 0.000 claims description 4
- 229940034610 toothpaste Drugs 0.000 claims description 4
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 claims description 3
- 206010006326 Breath odour Diseases 0.000 claims description 3
- 229960001245 olaflur Drugs 0.000 claims description 3
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011698 potassium fluoride Substances 0.000 claims description 3
- 235000003270 potassium fluoride Nutrition 0.000 claims description 3
- 239000011775 sodium fluoride Substances 0.000 claims description 3
- 235000013024 sodium fluoride Nutrition 0.000 claims description 3
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical group F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 3
- 229960002799 stannous fluoride Drugs 0.000 claims description 3
- GLWQRIMWMLJRIB-UHFFFAOYSA-N F.F.CCO Chemical compound F.F.CCO GLWQRIMWMLJRIB-UHFFFAOYSA-N 0.000 claims description 2
- 208000032139 Halitosis Diseases 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 230000032770 biofilm formation Effects 0.000 claims description 2
- XROWMBWRMNHXMF-UHFFFAOYSA-J titanium tetrafluoride Chemical compound [F-].[F-].[F-].[F-].[Ti+4] XROWMBWRMNHXMF-UHFFFAOYSA-J 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 1
- 150000004673 fluoride salts Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 10
- 239000003795 chemical substances by application Substances 0.000 description 22
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 17
- 150000003839 salts Chemical class 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 235000015424 sodium Nutrition 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 229910019142 PO4 Inorganic materials 0.000 description 9
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 9
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 150000002978 peroxides Chemical class 0.000 description 9
- 235000021317 phosphate Nutrition 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 8
- 235000003599 food sweetener Nutrition 0.000 description 8
- 239000002324 mouth wash Substances 0.000 description 8
- 239000003755 preservative agent Substances 0.000 description 8
- 239000003765 sweetening agent Substances 0.000 description 8
- 230000002087 whitening effect Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- 229940051866 mouthwash Drugs 0.000 description 7
- 159000000000 sodium salts Chemical class 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 239000004599 antimicrobial Substances 0.000 description 5
- 239000008376 breath freshener Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000003906 humectant Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 150000001342 alkaline earth metals Chemical class 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 4
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 208000006558 Dental Calculus Diseases 0.000 description 3
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960004867 hexetidine Drugs 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 150000004965 peroxy acids Chemical class 0.000 description 3
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229940084560 sanguinarine Drugs 0.000 description 3
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 3
- 229940071089 sarcosinate Drugs 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229940083542 sodium Drugs 0.000 description 3
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- RWMSXNCJNSILON-UHFFFAOYSA-N 2-[4-(2-propylpentyl)piperidin-1-yl]ethanol Chemical compound CCCC(CCC)CC1CCN(CCO)CC1 RWMSXNCJNSILON-UHFFFAOYSA-N 0.000 description 2
- AKDYIOMCKBOLRE-UHFFFAOYSA-N 2-tetradecylpyridine;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC1=CC=CC=N1 AKDYIOMCKBOLRE-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- FHEHIXJLCWUPCZ-UHFFFAOYSA-N 4-prop-2-enylbenzene-1,2-diol Chemical compound OC1=CC=C(CC=C)C=C1O FHEHIXJLCWUPCZ-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 239000000120 Artificial Saliva Substances 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- XJOZMBMWQJUQMN-UHFFFAOYSA-N CCCCCCCCCCCCCCN1C=CC(CC)=CC1.Cl Chemical compound CCCCCCCCCCCCCCN1C=CC(CC)=CC1.Cl XJOZMBMWQJUQMN-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 241000218378 Magnolia Species 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 244000263375 Vanilla tahitensis Species 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229910001919 chlorite Inorganic materials 0.000 description 2
- 229910052619 chlorite group Inorganic materials 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- JJLJMEJHUUYSSY-UHFFFAOYSA-L copper(II) hydroxide Inorganic materials [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 201000002170 dentin sensitivity Diseases 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229960001078 lithium Drugs 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229950002404 octapinol Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- XXQBEVHPUKOQEO-UHFFFAOYSA-N potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229960000414 sodium fluoride Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 229940045872 sodium percarbonate Drugs 0.000 description 2
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 159000000008 strontium salts Chemical class 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 230000036347 tooth sensitivity Effects 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- BYOBJKVGOIXVED-UHFFFAOYSA-N (2-phosphonoazepan-2-yl)phosphonic acid Chemical compound OP(O)(=O)C1(P(O)(O)=O)CCCCCN1 BYOBJKVGOIXVED-UHFFFAOYSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OIQLZRMTKKPPPE-UHFFFAOYSA-N 1,1-dihydroxypropane-1-sulfonic acid Chemical compound CCC(O)(O)S(O)(=O)=O OIQLZRMTKKPPPE-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- GEZAUFNYMZVOFV-UHFFFAOYSA-J 2-[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetan-2-yl)oxy]-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetane 2-oxide Chemical compound [Sn+2].[Sn+2].[O-]P([O-])(=O)OP([O-])([O-])=O GEZAUFNYMZVOFV-UHFFFAOYSA-J 0.000 description 1
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 description 1
- UOWIFEANNONTKY-UHFFFAOYSA-N 2-hydroxy-5-octanoyl-n-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 UOWIFEANNONTKY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
- OBFSQMXGZIYMMN-UHFFFAOYSA-N 3-chloro-2-hexadecylpyridine Chemical group CCCCCCCCCCCCCCCCC1=NC=CC=C1Cl OBFSQMXGZIYMMN-UHFFFAOYSA-N 0.000 description 1
- XSLBWJPPWWFTQY-UHFFFAOYSA-N 3-hydroperoxypropane-1,2-diol Chemical compound OCC(O)COO XSLBWJPPWWFTQY-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical group OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- 241000186044 Actinomyces viscosus Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940122361 Bisphosphonate Drugs 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical class [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical class [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 241000735332 Gerbera Species 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- KPIQXPLWZCDIHI-UHFFFAOYSA-N OC(=O)C1=NN(C=2C=CC(=CC=2)S(O)(=O)=O)C(O)=C1N=NC1=CC=C(S(O)(=O)=O)C=C1 Chemical compound OC(=O)C1=NN(C=2C=CC(=CC=2)S(O)(=O)=O)C(O)=C1N=NC1=CC=C(S(O)(=O)=O)C=C1 KPIQXPLWZCDIHI-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229920001090 Polyaminopropyl biguanide Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical group [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000002912 Salvia officinalis Nutrition 0.000 description 1
- 241000194025 Streptococcus oralis Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- CHBBKFAHPLPHBY-KHPPLWFESA-N [(z)-octadec-9-enyl] 2-(methylamino)acetate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CNC CHBBKFAHPLPHBY-KHPPLWFESA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000007961 artificial flavoring substance Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- ZJRXSAYFZMGQFP-UHFFFAOYSA-N barium peroxide Chemical compound [Ba+2].[O-][O-] ZJRXSAYFZMGQFP-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229940095672 calcium sulfate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940119201 cedar leaf oil Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- JFBJUMZWZDHTIF-UHFFFAOYSA-N chlorine chlorite Inorganic materials ClOCl=O JFBJUMZWZDHTIF-UHFFFAOYSA-N 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- AEJIMXVJZFYIHN-UHFFFAOYSA-N copper;dihydrate Chemical compound O.O.[Cu] AEJIMXVJZFYIHN-UHFFFAOYSA-N 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 description 1
- 229960003854 delmopinol Drugs 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical class OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960000878 docusate sodium Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 201000010840 enamel caries Diseases 0.000 description 1
- 201000005581 enamel erosion Diseases 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000005454 flavour additive Substances 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000004966 inorganic peroxy acids Chemical class 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- HPGPEWYJWRWDTP-UHFFFAOYSA-N lithium peroxide Chemical compound [Li+].[Li+].[O-][O-] HPGPEWYJWRWDTP-UHFFFAOYSA-N 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- WWOYCMCZTZTIGU-UHFFFAOYSA-L magnesium;2-carboxybenzenecarboperoxoate;hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].OOC(=O)C1=CC=CC=C1C([O-])=O.OOC(=O)C1=CC=CC=C1C([O-])=O WWOYCMCZTZTIGU-UHFFFAOYSA-L 0.000 description 1
- YRZGPQDNADQQOW-UHFFFAOYSA-L magnesium;potassium;phthalate Chemical compound [Mg+2].[K+].[O-]C(=O)C1=CC=CC=C1C([O-])=O YRZGPQDNADQQOW-UHFFFAOYSA-L 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 235000014569 mints Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000019659 mouth feeling Nutrition 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001706 oxygenating effect Effects 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000007406 plaque accumulation Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229940093424 polyaminopropyl biguanide Drugs 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229940094025 potassium bicarbonate Drugs 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000001327 prunus amygdalus amara l. extract Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 239000004172 quinoline yellow Substances 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- FZUOVNMHEAPVBW-UHFFFAOYSA-L quinoline yellow ws Chemical compound [Na+].[Na+].O=C1C2=CC=CC=C2C(=O)C1C1=NC2=C(S([O-])(=O)=O)C=C(S(=O)(=O)[O-])C=C2C=C1 FZUOVNMHEAPVBW-UHFFFAOYSA-L 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- HSSLDCABUXLXKM-UHFFFAOYSA-N resorufin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3N=C21 HSSLDCABUXLXKM-UHFFFAOYSA-N 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 229950000975 salicylanilide Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- YKOLYTVUIVUUDY-UHFFFAOYSA-K sodium;zinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Na+].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YKOLYTVUIVUUDY-UHFFFAOYSA-K 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- IRFHMTUHTBSEBK-QGZVFWFLSA-N tert-butyl n-[(2s)-2-(2,5-difluorophenyl)-3-quinolin-3-ylpropyl]carbamate Chemical compound C1([C@H](CC=2C=C3C=CC=CC3=NC=2)CNC(=O)OC(C)(C)C)=CC(F)=CC=C1F IRFHMTUHTBSEBK-QGZVFWFLSA-N 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000001789 thuja occidentalis l. leaf oil Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- SYMVZGYNJDKIPL-UHFFFAOYSA-H tricalcium;oxido phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]OP([O-])([O-])=O.[O-]OP([O-])([O-])=O SYMVZGYNJDKIPL-UHFFFAOYSA-H 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WBGSMIRITKHZNA-UHFFFAOYSA-M trisodium;dioxido(oxidooxy)borane Chemical compound [Na+].[Na+].[Na+].[O-]OB([O-])[O-] WBGSMIRITKHZNA-UHFFFAOYSA-M 0.000 description 1
- VBIJGJLWKWLWHQ-UHFFFAOYSA-K trisodium;oxido phosphate Chemical compound [Na+].[Na+].[Na+].[O-]OP([O-])([O-])=O VBIJGJLWKWLWHQ-UHFFFAOYSA-K 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229940071566 zinc glycinate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本發明說明包含氧化鋅和檸檬酸鋅組合之口腔護理組成物,及其之製備和使用方法。
Description
本發明說明包含氧化鋅和檸檬酸鋅組合之口腔護理組成物,及其製備和使用方法。
可溶性鋅鹽(諸如檸檬酸鋅)已被用於潔牙劑組成物中。對口腔護理產品中用於提供增強效益之劑有需求,包括增強抗菌、防齲齒、防琺瑯質侵蝕、口氣清新及類似者。特別對潔牙劑調配物中用於改進抗菌活性及提供改進之口腔生物膜減少之有效的鋅系統有需求。
在一些實施例中,其提供包含氧化鋅和檸檬酸鋅之口腔護理組成物,其中氧化鋅:檸檬酸鋅之重量比為1.5:1至4.5:1。在其他的實施例中,重量比為1.5:1至4:1,1.7:1至2.3:1,1.9:1至2.1:1,或約2:1。亦可使用以該等重量比為基準之對應的莫耳數比。
一些實施例提供治療或預防口腔疾病或症狀之方法,其包含將有需求之病患的口腔表面與本文所述之組成物中之任一者接觸。
亦提供氧化鋅和檸檬酸鋅在口腔護理組成物中用以減少或抑制口腔中生物膜形成之用途,其中氧化鋅:檸檬酸鋅之重量比為1.5:1至4.5:1。在其他的實施例中,重量比為1.5:1至4:1,1.7:
1至2.3:1,1.9:1至2.1:1,或約2:1。亦可使用以該等重量比為基準之對應的莫耳數比。
本發明的更多可應用領域將從下文所提供之詳細說明變得顯而易見。應瞭解指出本發明較佳的實施例之詳細說明和特定實施例僅意欲以例證為目的,並不意欲限制本發明的範圍。
以下較佳的具體實例之說明在性質上僅為示範,並不意欲以任何方式限制本發明、其應用或用途。
如全文中所使用之範圍係以說明在該範圍內的各個及每個數值之簡略方式使用。在該範圍內的任何數值可選擇作為該範圍的終點。另外,在本文所引述之所有參考文獻特此併入其全文以供參考。在本發明的定義與所引述之參考文獻的定義衝突的情況下,則以本發明為準。
應瞭解在本文及說明書的別處所表示的所有百分比及量係指重量百分比,除非另有其他指定。所給定之量係以材料的活性重量為基準。
已驚訝且意外地發現以特定比例之氧化鋅對檸檬酸鋅提供高的效力水平,例如減少口腔中的生物膜、增加抗微生物效應及類似者。
在一些實施例中,其係提供包含氧化鋅和檸檬酸鋅之口腔護理組成物,其中氧化鋅至檸檬酸鋅之重量比為1.5:1至4.5:1,視需要為1.5:1至4:1,1.7:1至2.3:1,1.9:1至2.1:1,或約2:1,且氧化鋅之量為以組成物重量計0.5至1.5%及檸檬酸鋅之量為以組成物重量計0.25至0.75%。在一些實施例中,氧化鋅之量為1%及檸檬酸鋅之量為0.5%。在一些實施例中,本發明的氧化鋅對檸檬酸鋅之比率的有效性提供抗微生物及/或抗口腔生物膜的協同效應。在一些實施例中,協同性地增加口腔軟或硬表面(例如牙齒)之鋅的遞輸或吸收。
組成物亦典型地包含口腔可接受之載劑或媒劑。載劑可包含研磨劑、增稠劑、保濕劑、聚合物、著色劑、黏度修飾劑、
泡沫調節劑、乳化劑、pH修飾劑、稀釋劑、口感劑、增甜劑、調味劑、防腐劑、適合的美容及/或治療活性物、及其組合。應瞭解雖然上述材料類別之各者的一般屬性不同,但是可能有一些共同的屬性且任何給出之材料可適合於此等材料類別中之二或多者內的多重目的。在組成物中的所有成分可具有除了彼之主要功能以外的功能,且可促成組成物的整體性質,包括其穩定性、效力、一致性、口感、味道、氣味等等。載劑較佳地係以與組成物的其他成分之相容性進行選擇。
載劑之特定組成物較佳地取決於組成物之意欲用
途。在各種實施例中,載劑為水性,其包含以重量計從5至95%之水,或以重量計從10至70%之水。在其他的實施例中,載劑實質上為非水性。在潔牙劑載劑中,水含量可以重量計從5至70%,從10至50%,或從20至40%。
在一些實施例中,組成物另外包含一或多種選自下
列之組份:氟化物離子來源、齒垢控制劑、緩衝劑、抗菌劑、研磨劑、及二或多種其之組合。
一些實施例提供其中一或多種組份中之至少一者為
選自下列的氟化物離子來源之組成物:氟化亞錫、氟化鈉、氟化鉀、單氟磷酸鈉、氟矽酸鈉、氟矽酸銨、氟化胺、氟化銨、及二或多種其之組合。
可包括其他視需要的添加劑。在此等視需要的添加
劑中,提供所包括的添加劑以便於改變外觀或審美訴求、及/或保存最終產品、及/或對味道/美容訴求、及/或作為口腔保健的治療和預防成分、預防或治療口腔的硬或軟組織之症狀或病症、或預防或治療生理病症或症狀。
一些實施例提供其中有防腐劑存在的組成物。在一
些實施例中,防腐劑係選自對羥苯甲酸酯(paraben)、山梨酸鉀、苯甲醇、苯氧基乙醇、聚胺基丙基雙胍、辛酸、苯甲酸鈉和氯化鯨蠟基吡錠。在一些實施例中,防腐劑係以重量計0.0001至1%之濃度存在。
著色劑(諸如染料)可為目前經食品藥物及化妝品法
(Food Drug & Cosmetic Act)認證之用於食品及攝取之藥物的食品顏色
添加劑,包括染料,諸如FD&C紅3號(四碘螢光素之鈉鹽)、食品紅17(6-羥基-5-{(2-甲氧基-5-甲基-4-磺苯基)偶氮基}-2-萘磺酸之二鈉鹽)、食品黃13(喹啉黃或2-(2-喹啉基)茚滿二酮的單與二磺酸混合物之鈉鹽)、FD&C黃5號(4-對-磺苯基偶氮基-1-對-磺苯基-5-羥基吡唑-3-羧酸之鈉鹽)、FD&C黃6號(對-磺苯基偶氮基-B-萘酚-6-單磺酸鹽之鈉鹽)、FD&C綠3號(4-{[4-(N-乙基-對-磺苯甲基胺基)-苯基]-(4-羥基-2-鋶苯基)-亞甲基}-[1-(N-乙基-N-對-磺苯甲基)-DELTA-3,5-環己二烯亞胺]之二鈉鹽)、FD&C藍1號(二苯甲基二乙基-二胺基-三苯基甲醇三磺酸硬石膏之二鈉鹽)、FD&C藍2號(靛藍的二磺酸之鈉鹽)、及其以各種比例的混合物。若包括著色劑,其典型地以非常少量存在。
調味劑包括但不限於天然和人造香料。該等調味可
選自合成香料油和調味芳香物、及/或油、油性樹脂和從植物、樹葉、花卉、水果等等所衍生之萃取物、及其組合。代表性香料油包括:綠薄荷油、桂皮油、薄荷油、丁香油、香葉油、瑞香草油、雪松葉油、肉豆蔻油、鼠尾草油和苦杏仁油。該等調味劑可個別或呈摻混物使用。一般使用的香料包含薄荷屬植物(諸如薄荷)、人造香草、桂皮衍生物和各種水果香料,不論以個別或呈摻混物使用。通常可使用任何調味劑或食品添加劑,諸如那些在國家科學院出版的1274期《食品加工中使用的化學物質》(Chemicals Used in Food Processing),第63-258頁中所述者。若包括調味劑,其典型地以重量計從0.01至1%之濃度存在。在一些實施例中,調味劑可以重量計0.2%之濃度存在。
增甜劑包括天然和人造增甜劑二者。適合的增甜劑
包括水溶性增甜劑,諸如單醣、雙醣和多醣,諸如木糖、核糖、葡萄糖(右旋糖)、甘露糖、半乳糖、果糖(左旋糖)、蔗糖(糖)、麥芽糖,水溶性人造增甜劑,諸如水溶性糖精鹽(亦即鈉或鈣糖精鹽),以賽克拉美(cyclamate)鹽二肽為主的增甜劑,諸如經L-天冬胺酸所衍生之增甜劑,諸如L-天冬胺醯基-L-苯基丙胺酸甲酯(阿斯巴甜)。通常使用有效量的增甜劑以提供特別的組成物所欲之甜味水平,該量將隨所選擇的增甜劑而改變。此量正常係以重量計從0.001至約5%。在一些實施例中,增甜劑為糖精鈉且以重量計0.01%之濃度存在。
可將增白劑(有效達到被塗敷之牙齒表面增白的材
料)併入組成物中,諸如過氧化氫和過氧化脲、高潔淨矽石、防腐劑、聚矽氧及葉綠素化合物。在各種實施例中,組成物包含過氧化物增白劑,其包含過氧化物化合物。過氧化物化合物為包含二價氧-氧基團之氧化化合物。過氧化物化合物包括過氧化物和氫過氧化物,諸如過氧化氫、鹼與鹼土金屬之過氧化物、有機過氧基化合物、過氧酸、其醫藥上可接受之鹽及其混合物。鹼與鹼土金屬之過氧化物包括過氧化鋰、過氧化鉀、過氧化鈉、過氧化鎂、過氧化鈣、過氧化鋇及其混合物。有機過氧基化合物包括胺甲醯胺過氧化物(亦已知為過氧化脲)、甘油基過氧化氫、烷基過氧化氫、二烷基過氧化物、烷基過氧酸、過氧酯、二醯基過氧化物、苯甲醯基過氧化物和單過氧酞酸酯,及其混合物。過氧酸和其鹽包括有機過氧酸,諸如烷基過氧酸、單過氧酞酸酯及其混合物,以及無機過氧酸鹽,諸如鹼與鹼土金屬(諸如鋰、鉀、鈉、鎂、鈣和鋇)之過硫酸鹽、二過硫酸鹽、過碳酸鹽、過磷酸鹽、過硼酸鹽和過矽酸鹽,及其混合物。在各種實施例中,過氧化物化合物包含過氧化氫、過氧化脲、過碳酸鈉及其混合物。在一些實施例中,過氧化物化合物包含過氧化氫。在一些實施例中,過氧化物化合物基本上由過氧化氫所組成。在一些實施例中,可提供非過氧化物增白劑。在本文有用的增白劑之中包括非過氧基化合物,諸如二氧化氯、亞氯酸鹽和次氯酸鹽。亞氯酸鹽和次氯酸鹽包括鹼與鹼土金屬(諸如鋰、鉀、鈉、鎂、鈣和鋇)的該等鹽。非過氧化物增白劑亦包括著色劑,諸如二氧化鈦及羥磷灰石。一或多種增白劑視需要以有效的牙齒增白總量存在。在一些實施例中,增白劑係與水性載劑分開。在一些實施例中,增白劑係藉由包封增白劑而與水性載劑分開。
視需要提供口氣清新劑。可使用包括而不限之任何
口腔可接受之口氣清新劑。一或多種口氣清新劑視需要以有效的口氣清新總量存在。
其他的實施例提供其中一或多種組份中之至少一者
為齒垢控制劑的組成物。在本文有用的那些齒垢控制劑之中包括磷酸鹽和聚磷酸鹽(例如,焦磷酸鹽)、聚胺基丙烷磺酸(AMPS)、聚烯烴磺
酸酯、聚烯烴磷酸酯、二膦酸酯,諸如氮雜環烷-2,2-二膦酸酯(例如,氮雜環庚烷-2,2-二膦酸)、N-甲基氮雜環戊烷-2,3-二膦酸、乙烷-1-羥基-1,1-二膦酸(EHDP)和乙烷-1-胺基-1,1-二膦酸酯、膦醯基烷羧酸、及該等劑中之任一者的鹽,例如彼之鹼金屬鹽和銨鹽。有用的無機磷酸鹽和聚磷酸鹽包括一元、二元和三元磷酸鈉、三聚磷酸鈉、四聚磷酸鈉、焦磷酸一、二、三和四鈉、三偏磷酸鈉、六偏磷酸鈉及其混合物,其中鈉可視需要被鉀或銨替代。其他有用的抗結石劑包括聚羧酸酯聚合物和聚乙烯基甲醚/順丁烯二酐(PVME/MA)共聚物,諸如那些自ISP,Wayne,N.J以GantrezTM品牌可得者。在一些實施例中,磷酸鹽係以重量計從0.01至10%之濃度存在。在一些實施例中,磷酸鹽係以重量計從1%之濃度存在。
一些實施例提供其中有緩衝劑存在的組成物。在一
些實施例中,一元磷酸鈉係以重量計從0.01至5%之濃度存在。在一些實施例中,一元磷酸鈉係以重量計1%之濃度存在。在一些實施例中,二元磷酸鈉係以重量計從0.01至5%之濃度存在。在一些實施例中,二元磷酸鈉係以重量計0.15%之濃度存在。
其他視需要的添加劑包括抗微生物(例如,抗菌)
劑。可使用任何口腔可接受之抗微生物劑,包含三氯沙(triclosan)(5-氯-2-(2,4-二氯苯氧基)酚);8-羥基喹啉和其鹽、鋅和亞錫離子來源,諸如檸檬酸鋅、硫酸鋅、甘胺酸鋅、檸檬酸鋅鈉和焦磷酸亞錫;銅(II)化合物,諸如氯化、氟化、硫酸和氫氧化銅(II);酞酸和其鹽,諸如酞酸單鉀鎂;血根鹼;四級銨化合物,諸如氯化烷基吡錠(例如,氯化鯨蠟基吡錠(CPC)、CPC與鋅及/或酵素之組合、氯化十四烷基吡錠和氯化N-十四烷基-4-乙基吡錠);縮二胍,諸如氯己啶(chlorhexidine)二葡糖酸鹽、海克替啶(hexetidine)、奥替尼啶(octenidine)、阿來西啶(alexidine);鹵化雙酚化合物,諸如2,2'亞甲基雙-(4-氯-6-溴酚);氯化烷基二甲基苯甲銨(benzalkonium chloride);水楊醯替苯胺、度米氛(domiphen)溴化物;碘;磺醯胺;雙縮二胍(bisbiguanide);酚系;哌啶基衍生物,諸如地莫品諾(delmopinol)和辛哌醇(octapinol);木蘭萃出物;葡萄籽萃出物;百里酚;丁子香酚;薄荷醇;香葉草醇;香旱
芹酚;檸檬醛;桉樹油;兒茶酚;4-烯丙基兒茶酚;己基間苯二酚;水楊酸甲酯;抗生素,諸如歐格門汀(augmentin)、安莫西林(amoxicillin)、四環黴素(tetracycline)、強力黴素(doxycycline)、米諾環素(minocycline)、美妥尼達索(metronidazole)、新黴素、康黴素和克林達黴素(clindamycin);及其混合物。有用的抗菌劑之進一步例證名單提供在1998年7月7日頒予Gaffar等人之美國專利案號5,776,435中。在一些實施例中,抗微生物劑係以重量計從0.001至1%之濃度存在。在一些實施例中,抗微生物劑為氯化鯨蠟基吡錠。在一些實施例中,氯化鯨蠟基吡錠係以重量計從0.001至1%之濃度存在。在其他的實施例中,氯化鯨蠟基吡錠係以重量計0.05%之濃度存在。
抗氧化劑為另一類別之視需要的添加劑。可使用任
何口腔可接受之抗氧化劑,包括丁基化羥基甲氧苯(BHA)、丁基化羥基甲苯(BHT)、維生素A、類胡蘿蔔素、維生素E、類黃酮、多酚、抗壞血酸、草藥抗氧化劑、葉綠素、褪黑激素及其混合物。
亦可視需要包括有用於例如改善口乾的唾液刺激
劑。可使用任何口腔可接受之唾液刺激劑,包括而非限制食用酸,諸如檸檬酸、乳酸、蘋果酸、琥珀酸、抗壞血酸、己二酸、反丁烯二酸和酒石酸,及其混合物。一或多種唾液刺激劑視需要係以有效的唾液刺激總量存在。
可視需要包括抗菌斑(例如,菌斑破壞)劑。可使用
任何口腔可接受之抗菌斑劑,包括非限制亞錫、銅、鎂和鍶鹽、聚二甲基矽氧烷(dimethicone)共聚物,諸如鯨蠟基聚二甲基矽氧烷共聚醇,木瓜酶、葡萄糖澱粉酶、葡萄糖氧化酶、尿素、乳酸鈣、甘油磷酸鈣、聚丙烯酸鍶及其混合物。
視需要的脫敏劑包括檸檬酸鉀、氯化鉀、酒石酸鉀、
碳酸氫鉀、草酸鉀、硝酸鉀、鍶鹽及其混合物。
視需要的添加劑亦包括維生素、草藥和蛋白質。維
生素包括維生素C和D、硫胺素、核黃素、泛酸鈣、菸鹼酸、葉酸、菸鹼醯胺、吡哆醇、氰鈷胺、對-胺基苯甲酸、生物類黃酮(bioflavonoid)、維生素B5(pantheon)、棕櫚酸視網酯、生育酚乙酸酯及
其混合物。亦可視需要包括草藥,諸如螢甘菊(Chamomilla recutita)、胡椒薄荷(Mentha piperita)、鼠尾草(Salvia officinalis)和沒藥(Commiphora myrrha)。適合的蛋白質包括牛奶蛋白質和酵素,諸如過氧化物製造酵素、澱粉酶、菌斑破壞劑,諸如木瓜酶、葡萄糖澱粉酶、葡萄糖氧化酶和「次世代」酵素(next generation enzyme)。
在一些實施例中,組成物具有以重量計大於10%之游離水含量。在一些實施例中,組成物具有以重量計大於11重量%之游離水含量。在其他的實施例中,組成物具有以重量計大於12重量%之游離水含量。又其他的實施例提供其中游離水含量係以重量計大於13%之組成物。還其他的實施例提供具有游離水含量以重量計大於14%之組成物。在一些實施例中,組成物具有以重量計大於15%之游離水含量。同時其他的實施例提供具有游離水含量以重量計大於16%之組成物。在一些實施例中,組成物具有以重量計17%之游離水含量。在一些實施例中,組成物具有以重量計大於17%之游離水含量。在一些實施例中,組成物具有以重量計從10%至約20%之游離水含量。
在一些實施例中,載劑包含保濕劑,諸如甘油、山梨醇或伸烷二醇,諸如聚乙二醇或丙二醇。在一些實施例中,載劑包含以組成物重量計從10至80%,或20至60%之水平的保濕劑。在本文中有用的那些載劑組成物係揭示於頒予Garlick,Jr..等人之美國專利5,695,746及Mei-King Ng等人之美國專利4,839,157中。
在本文有用的增稠劑或膠凝劑包括無機、天然或合成增稠劑或膠凝劑。在一些組態中,載劑包含以組成物重量計從0.1至15%,或從0.4至10%之總水平的增稠劑或膠凝劑。在本文有用的增稠劑或膠凝劑之實例包括無機增稠矽石,諸如:非晶形矽石,例如Zeodent® 165(Huber公司);鹿角菜;ι-角叉菜膠(iota-carrageenan);黃蓍膠;或聚乙烯基吡咯啶酮。
在特定的實施例中,載劑包含研磨劑或或拋光劑,諸如矽石、煅燒氧化鋁、碳酸氫鈉、碳酸鈣、磷酸二鈣或焦磷酸鈣。在各種實施例中,載劑為澄清的。在各種實施例中,載劑包含以組成物重量計從5至70%之程度的研磨劑。
在一些實施例中,組成物包含界面活性劑或界面活
性劑之混合物。在本文有用的那些界面活性劑中包括至少一種高碳脂肪酸單甘油酯單硫酸鹽之水溶性鹽,諸如氫化椰子油脂肪酸之單硫酸化單甘油酯之鈉鹽;椰油醯胺基丙基甜菜鹼;高碳烷基硫酸鹽,諸如月桂基硫酸鈉;烷基芳基磺酸鹽,諸如十二烷基苯磺酸鈉;高碳烷基磺乙酸鹽;月桂基磺乙酸鈉;1,2-二羥基丙烷磺酸之高碳脂肪酸酯;及低碳脂族胺基羧酸之實質上飽和的高碳脂族醯基醯胺,諸如那些在脂肪酸、烷基或醯基上具有12至16個碳者;及其混合物。醯胺可為例如N-月桂醯基肌胺酸,及N-月桂醯基肌胺酸、N-肉豆蔻醯基肌胺酸或N-棕櫚醯基肌胺酸之鈉鹽、鉀鹽和乙醇胺鹽。在各種實施例中,界面活性劑係以組成物重量計從0.3至5%,或0.5至3%之濃度存在。
在第一個實施例中,其提供口腔用組成物(組成物
1),該組成物包含例如口腔護理組成物,其包含氧化鋅和檸檬酸鋅,其中氧化鋅:檸檬酸鋅之重量比為1.7:1至2.3:1,視需要為1.9:1至2.1:1,或約2:1;例如:1.1.組成物1,其中氧化鋅之量為以組成物重量計0.5至1.5%,及檸檬酸鋅之量為以組成物重量計0.25至0.75%;1.2.組成物1.1,其中氧化鋅之量為1%,及檸檬酸鋅之量為0.5%;1.3.前述組成物中之任一者,其進一步包含有效量的氟化物,例如其中氟化物為選自氟化亞錫、氟化鈉、氟化鉀、單氟磷酸鈉、氟矽酸鈉、氟矽酸銨、氟化胺(例如,N'-十八烷基丙二胺-N,N,N'-三(2-乙醇)-二氫氟化物)、氟化銨、氟化鈦、六氟硫酸鹽及其組合之鹽;1.4.前述組成物中之任一者,其包含呈游離形式或口腔可接受之鹽形式的L-精胺酸;1.5.前述組成物中之任一者,其包含緩衝劑,例如磷酸鈉緩衝液(例如,一元磷酸鈉和磷酸二鈉);1.6.前述組成物中之任一者,其包含保濕劑,例如選自甘油、山梨醇、聚乙二醇、聚乙二醇、木糖醇及其混合物;1.7.前述組成物中之任一者,其包含研磨劑或微粒;
1.8.緊接於前述之組成物,其中研磨劑或微粒係選自碳酸氫鈉、磷酸鈣(例如,二水合磷酸二鈣)、硫酸鈣、沉澱碳酸鈣、焦磷酸鈣、矽石(例:含水矽石)、氧化鐵、氧化鋁、珍珠岩、塑膠粒子,例如聚乙烯,及其組合;1.9.前述組成物中之任一者,其包含以組成物總重量計15重量%至70重量%之量的研磨劑;1.10.前述組成物中之任一者,其包含一或多種界面活性劑,例如選自陰離子、陽離子、兩性離子和非離子性界面活性劑,及其混合物,例如包含陰離子界面活性劑,例如選自月桂基硫酸鈉、醚月桂基硫酸鈉及其混合物之界面活性劑,例如以重量計從0.3%至4.5%之量;1.11.前述組成物中之任一者,其進一步包含黏度修飾量的一或多種聚合物,其係選自聚乙二醇、多醣(例如,纖維素衍生物,例如羧甲基纖維素,多醣膠,例如三仙膠或角叉菜膠),及其組合;1.12.前述組成物中之任一者,其呈潔牙劑、漱口水、咀嚼膠或錠劑形式;1.13.前述組成物中之任一者,其進一步包含調味劑、香料及/或著色劑;1.14.前述組成物中之任一者,其進一步包含水;1.15.前述組成物中之任一者,其包含一或多種抗菌劑,例如包含選自下列之抗菌劑:鹵化二苯醚(例如,三氯沙),草藥萃取物和精油(例如,迷迭香萃取物、茶萃取物、木蘭萃取物、百里酚、薄荷醇、桉樹油、香葉草醇、香旱芹酚、檸檬醛、檜木醇、兒茶酚、水楊酸甲酯、表沒食子兒茶素沒食子酸酯(epigallocatechin gallate)、兒茶素(epigallocatechin)、沒食子酸、密斯瓦克(miswak)萃取物、沙棘萃取物)、雙胍防腐劑(例如,氯己啶、阿來西啶或奧替尼啶)、四級銨化合物(例如,氯化鯨蠟基吡錠(CPC)、氯化烷基二甲基苯甲銨、氯化十四烷基吡錠(TPC)、氯化N-十四烷基-4-乙基吡錠(TDEPC))、酚系防腐劑、海克替啶、奥替尼啶、血根鹼、聚維酮碘、地莫品諾、5-正辛醯-3’-三氟甲基苯基水楊醯胺(salifluor)、金屬離子(例如,鋅鹽,例如檸檬酸鋅、亞錫鹽、銅鹽、鐵鹽)、血根鹼、蜂膠及充氧劑(oxygenating
agents)(例如,過氧化氫、經緩衝之過氧硼酸鈉或過氧碳酸鈉)、酞酸和其鹽、單過氧鄰苯二甲酸(monoperthalic acid)和其鹽與酯、抗壞血酸硬脂酸酯、油醯基肌胺酸、硫酸烷酯、磺琥珀酸二辛酯、水楊醯替苯胺、度米氛溴化物、地莫品諾、辛哌醇(octapinol)、及其他的哌啶基衍生物、乳酸鏈球菌素(nicin preparations)、亞氯酸鹽;及前述中之任一者的混合物;例如包含三氯沙或氯化鯨蠟基吡錠;1.16.前述組成物中之任一者,其進一步包含增白劑,例如選自由下列者所組成的群組:過氧化物、金屬亞氯酸鹽、過硼酸鹽、過碳酸鹽、過氧酸、次氯酸鹽及其組合;1.17.前述組成物中之任一者,其進一步包含過氧化氫或過氧化氫來源,例如過氧化脲或過氧化物鹽或複合物(例如,諸如過氧磷酸鹽、過氧碳酸鹽、過硼酸鹽、過氧矽酸鹽或過硫酸鹽;例如過氧磷酸鈣、過硼酸鈉、過氧化碳酸鈉、過氧磷酸鈉和過硫酸鉀);1.18.前述組成物中之任一者,其進一步包含干擾或防止細菌附著之劑,例如對羥基苯甲酸乙酯(solbrol)或幾丁聚醣;1.19.前述組成物中之任一者,其進一步包含鈣和磷酸鹽來源,其係選自(i)鈣-玻璃複合物,例如磷矽酸鈉鈣,及(ii)鈣-蛋白質複合物,例如酪蛋白磷酸肽-非晶形磷酸鈣;1.20.前述組成物中之任一者,其進一步包含可溶性鈣鹽,例如選自硫酸鈣、氯化鈣、硝酸鈣、乙酸鈣、乳酸鈣及其組合;1.21.前述組成物中之任一者,其進一步包含生理上或口腔可接受之鉀鹽,例如硝酸鉀或檸檬酸鉀,其量有效降低牙敏感性;1.22.前述組成物中之任一者,其進一步包含口氣清新劑、香料或調味劑;1.23.前述組成物中之任一者,其在應用於口腔時有效,例如以刷牙,以(i)降低牙齒敏感性,(ii)減少菌斑累積,(iii)減少或抑制去礦質化作用且促進牙齒的再礦質化作用,(iv)抑制口腔內的微生物形成生物膜,(v)減少或抑制牙齦炎,(vi)促進嘴巴內的潰瘍或傷口癒合,(vii)減少產酸細菌量,(viii)增加非致齲及/或非菌斑形成細菌的相對值,(ix)減少或抑制齲齒的形成,(x)減少、修復或抑制琺瑯質的齲齒
前損傷,例如如以定量光誘導之螢光(QLF)或電氣齲齒測量(ECM)所檢測,(xi)治療、緩解或減輕口乾,(xii)清潔牙齒和口腔,(xiii)減少侵蝕,(xiv)美白牙齒,及/或(xv)促進全身健康,包括心血管健康,例如藉由降低經由口腔組織的全身性感染之可能性;1.24.藉由組合在前述組成物中之任一者所列舉之成分而獲得或可獲得的組成物;1.25.前述組成物中之任一者,其中組成物為牙膏或漱口水,其視需要進一步包含水、研磨劑、界面活性劑、發泡劑、維生素、聚合物、酵素、保濕劑、增稠劑、抗微生物劑、防腐劑、調味料、著色劑及/或其組合中之一或多者;1.26.前述組成物中之任一者,其中組成物為牙膏。
在一些實施例中,氧化鋅和檸檬酸鋅不內含在膜中。在一些實施例中,氧化鋅和檸檬酸鋅係呈單一相。
一些實施例提供一種治療或預防口腔疾病或症狀之方法,其包含將需要其之病患的口腔表面與本文所述之組成物中之任一者接觸。在其他的實施例中,口腔的疾病或症狀為口臭。在一些實施例中,其提供一種減少在需要其之個體口腔中的揮發性硫化合物之方法。在進一步的實施例中,其提供一種增加金屬離子遞輸至口腔表面之方法。
在特定的實施例中,本文所述之組成物可用於例如預防齲齒、美白、預防或減少牙菌斑、預防或減少牙齦炎、控制齒垢、預防或減少口氣惡臭和預防色斑。
適合於組成物之產物形式的實例包括潔牙劑、漱口水、咀嚼膠和錠劑。
一種類型的產物形式為潔牙劑。術語「潔牙劑」通常表示被用於清潔口腔表面之調配物。潔牙劑為無意以全身性投予治療劑為目的而吞嚥,但是塗敷於口腔、用於處理口腔及接著吐出的口腔用組成物。潔牙劑通常連同清潔用具一起使用,諸如牙刷,通常將其塗敷於牙刷的刷毛及接著刷洗可觸及的口腔表面。潔牙劑較佳地呈糊狀物或凝膠(或其組合)。
另一類型的產物形式為漱口水。術語「漱口水」通常表示被用於沖洗口腔表面且提供使用者口腔清潔及清涼感覺的液體調配物。漱口水為無意以全身性投予治療劑為目的而吞嚥,但是施予口腔、用於處理口腔及接著吐出的口腔用組成物。漱口水組成物經常含有連續水相。水量通常在以漱口水總重量為基準計從70至99重量%之範圍內。
本文所述之組成物可以根據那些熟諳本技藝者輕易已知的方法製備。
本發明的實施例於以下的實施例中進一步說明。實施例僅為例證且不以任何方式限制如所述和申請之範圍。
使用以代謝指示劑染料刃天青(resazurin)為基礎之檢定法,測試在標準的牙膏調配物中,具有不同量及比率之氧化鋅和檸檬酸鋅的配方,以評定在處理之後的細菌生存力。以五種代表性口腔物種的物種混合物用於此檢定法中(黏放線菌(Actinomyces viscosus)、乾酪乳桿菌(Lactobacillus casei)、口腔鏈球菌(Streptococcus oralis)、細梭菌(Fusobacterium nucleatum)和小韋永氏球菌(Veillonella parvula))且以1:100之潔牙劑的最終濃度處理。在以50μg/ml之刃天青溶液染色之前,將細菌以試驗溶液培育1小時。當能活的細菌與刃天青培育時,藍色無螢光染料被細菌還原成粉紅色螢光染料試鹵靈(resorufin)。試驗樣品的螢光係在560奈米激發/590奈米發射下讀取,且與活著及死掉的細菌之標準化混合物的螢光相比,以測定在處理之後,仍能存活的最初群體之百分比。結果於表1中。
表1中的結果顯示比率為2:1之氧化鋅:檸檬酸鋅有
較少能存活的群體。此結果甚至比兩種具有更高的鋅總濃度之調配物更好。
在以下的實施例中,所使用之實驗方法為曼徹斯特大學的生物膜生長抑制模式。此模式之規程係如下:
(1)收集4位自願者的牙菌斑且一起匯聚成接種物。接種物之光學密度在610奈米下符合0.3之吸收值。
(2)將無菌羥磷灰石(HAP)盤片在厭氧條件下,於37℃以1毫升無菌人造唾液(具有0.01重量%之蔗糖)及1毫升匯聚之唾液,在24槽孔微量盤中培育24小時。
(3)就各試驗潔牙劑(及各對照組),製得以重量計1份潔牙劑:2份無菌蒸餾水之處理溶液。將各新鮮製備之處理溶液添加至三個槽孔中,且容許接觸其中的HAP盤片10分鐘。
(4)接著移出每一槽孔之液相,且以2毫升無菌人造唾液替代。
(5)接著將盤片在厭氧條件下於37℃下維持8天。
(6)在2、4及8天的間隔,經無菌收集盤片且轉移至半強度的預還原之氫硫乙酸培養基中(每一盤片4.5毫升)。
(7)將100微升稀釋液10-4、10-5和10-6就各盤片重複兩次塗佈在用於總格蘭陰性(Gram negative)厭氧菌的新黴素(Neomycin)/萬古黴素(Vancomycin)(NV)洋菜上。
(8)使用無菌散佈器表面散佈於微量盤,且於37℃下經厭氧培育72小時,隨後計數在各微量盤上的菌落數。
計算各試驗潔牙劑或對照組之log10 CFU/毫升(其中CFU=菌落形成單位)。較低的Log10 CFU/毫升表示所測試之潔牙劑對抑制生物膜生長具有更大的效力。
實施例2
將使用曼徹斯特大學的生物膜生長抑制模式之方法
(如上)所獲得的結果顯示於表2中,在方法的步驟6中經8天培育之盤片獲得平均的log10 CFU/毫升。
Claims (9)
- 一種口腔護理組成物,其包含氧化鋅和檸檬酸鋅,其中該氧化鋅之量為1%,及該檸檬酸鋅之量為0.5%;以及有效量之氟化物,其中該氟化物鹽係選自氟化亞錫、氟化鈉、氟化鉀、氟矽酸鈉、氟矽酸銨、氟化胺、氟化銨、氟化鈦、六氟硫酸鹽及其組合。
- 根據申請專利範圍第1項之組成物,更包含口腔可接受之載劑。
- 根據申請專利範圍第1或2項之組成物,其呈潔牙劑形式。
- 根據申請專利範圍第1或2項之組成物,其呈牙膏或牙膠形式。
- 根據申請專利範圍第1或2項之組成物,其中該組成物包含以重量計大於15%之游離水。
- 根據申請專利範圍第1或2項之組成物,其中該氟化胺為N'-十八烷基丙二胺-N,N,N'-三(2-乙醇)-二氫氟化物。
- 一種根據申請專利範圍第1至6項中任一項之組成物的用途,其係用於製造治療或預防口腔疾病或症狀之口腔護理產品。
- 根據申請專利範圍第7項之用途,其中該口腔疾病或症狀為口臭。
- 一種根據申請專利範圍第1-6項中任一項之組成物於製造口腔護理組成物的用途,以減少或抑制口腔中的生物膜形成。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
??201310701692.8 | 2013-12-19 | ||
CN201310701692.8A CN104721063B (zh) | 2013-12-19 | 2013-12-19 | 包含氧化锌和柠檬酸锌的洁齿剂组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201609169A TW201609169A (zh) | 2016-03-16 |
TWI642446B true TWI642446B (zh) | 2018-12-01 |
Family
ID=52293290
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103143993A TWI642446B (zh) | 2013-12-19 | 2014-12-17 | 包含氧化鋅和檸檬酸鋅之潔牙劑組成物 |
TW106121003A TW201811300A (zh) | 2013-12-19 | 2014-12-17 | 包含氧化鋅和檸檬酸鋅之潔牙劑組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW106121003A TW201811300A (zh) | 2013-12-19 | 2014-12-17 | 包含氧化鋅和檸檬酸鋅之潔牙劑組成物 |
Country Status (17)
Country | Link |
---|---|
US (3) | US10342750B2 (zh) |
EP (1) | EP3082725B1 (zh) |
JP (1) | JP2017500331A (zh) |
KR (1) | KR20160093627A (zh) |
CN (1) | CN104721063B (zh) |
AR (1) | AR098882A1 (zh) |
AU (1) | AU2014364436B2 (zh) |
BR (1) | BR112016013496B1 (zh) |
CA (1) | CA2927624C (zh) |
CL (1) | CL2016001544A1 (zh) |
IL (1) | IL245776A (zh) |
MX (1) | MX367036B (zh) |
MY (1) | MY161447A (zh) |
PH (1) | PH12016501006A1 (zh) |
RU (1) | RU2649804C1 (zh) |
TW (2) | TWI642446B (zh) |
WO (1) | WO2015095627A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4331561A1 (en) * | 2022-08-31 | 2024-03-06 | Unilever IP Holdings B.V. | Use of oral care composition |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104721063B (zh) | 2013-12-19 | 2018-05-08 | 高露洁-棕榄公司 | 包含氧化锌和柠檬酸锌的洁齿剂组合物 |
WO2016105438A1 (en) | 2014-12-26 | 2016-06-30 | Colgate-Palmolive Company | Low water dentifrice compositions |
US12109442B2 (en) | 2014-12-26 | 2024-10-08 | Colgate-Palmolive Company | Oral care compositions and methods of use |
CN107205895B (zh) * | 2015-07-01 | 2021-11-05 | 高露洁-棕榄公司 | 口腔护理组合物及使用方法 |
ITUA20162167A1 (it) * | 2016-03-31 | 2017-10-01 | Bio Eco Active S R L | Manufatto comprendente un agente ad azione antiossidante e un agente ad azione batteriostatica e relativo processo di produzione. |
US20170326054A1 (en) * | 2016-05-11 | 2017-11-16 | Nestec Sa | Compositions and methods for reducing or preventing dental calculus accumulation in companion animals |
EP3474812B1 (en) | 2016-06-24 | 2023-11-29 | Colgate-Palmolive Company | Oral care compositions |
RU2744785C2 (ru) * | 2016-06-24 | 2021-03-15 | Колгейт-Палмолив Компани | Композиции для ухода за полостью рта и способы их применения |
BR112018075975B1 (pt) | 2016-06-24 | 2022-07-19 | Colgate-Palmolive Company | Composição para higiene bucal |
WO2017223311A1 (en) | 2016-06-24 | 2017-12-28 | Colgate-Palmolive Company | Oral care compositions |
EP3386467B1 (en) | 2016-06-24 | 2023-08-30 | Colgate-Palmolive Company | Oral care compositions and their use in treating dental erosion |
US10617620B2 (en) | 2016-06-24 | 2020-04-14 | Colgate-Palmolive Company | Oral care compositions and methods of use |
US10058493B2 (en) | 2016-12-21 | 2018-08-28 | Colgate-Palmolive Company | Oral care compositions and methods of use |
BR112019012119B1 (pt) | 2016-12-21 | 2022-09-06 | Colgate-Palmolive Company | Composições para higiene bucal e uso de uma fonte de zinco |
US11154468B2 (en) | 2016-12-21 | 2021-10-26 | Colgate-Palmolive Company | Oral care compositions and methods of use |
EP3658106A1 (en) * | 2017-08-31 | 2020-06-03 | Colgate-Palmolive Company | Oral care compositions |
JP2020033315A (ja) * | 2018-08-31 | 2020-03-05 | 株式会社 ニュー・サイエンス | 歯磨き剤 |
CN113194939B (zh) | 2018-12-20 | 2024-09-17 | 高露洁-棕榄公司 | 用于治疗口腔中的胃病症状的包含锌和氨基酸的口腔护理组合物 |
US11026881B2 (en) * | 2019-01-02 | 2021-06-08 | Daniel S. Nam | Sedative laced toothpaste |
EP3958983A1 (en) * | 2019-04-26 | 2022-03-02 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
KR102221917B1 (ko) * | 2019-07-01 | 2021-03-03 | 김천균 | 시린 이 및 치주질환 방지용 치약의 제조방법 |
EP4034072A4 (en) | 2019-09-25 | 2023-11-08 | Church & Dwight Co., Inc. | ORAL CARE COMPOSITION |
US11850233B2 (en) | 2019-10-28 | 2023-12-26 | Matibur Rahaman Zamadar | Reduced adaptive microbial resistance treatment for flesh eating disease (necrotizing fasciitis) |
EP4021386A1 (en) | 2020-03-27 | 2022-07-06 | Colgate-Palmolive Company | Oral care compositions and methods of use |
WO2022026672A1 (en) | 2020-07-31 | 2022-02-03 | Colgate-Palmolive Company | Process for producing an oral care composition |
MX2023013949A (es) | 2021-05-25 | 2023-12-11 | Colgate Palmolive Co | Composiciones para el cuidado bucal. |
WO2023164709A1 (en) * | 2022-02-25 | 2023-08-31 | Beirne Ashley | Teeth stain blocking composition and method of use |
WO2023247292A1 (en) * | 2022-06-23 | 2023-12-28 | Unilever Ip Holdings B.V. | Oral care composition for mitigation and/or reversion of erosion of tooth enamel caused by wearing an aligner |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201231056A (en) * | 2010-12-21 | 2012-08-01 | Colgate Palmolive Co | Metal salt compositions |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4469674A (en) | 1981-09-03 | 1984-09-04 | Richardson-Vicks Inc. | Stable oral compositions containing zinc and fluoride compounds |
FR2686020B1 (fr) * | 1992-01-15 | 1994-05-13 | Oreal | Composition a usage buccal destinee a eviter la formation de taches sur les dents, leur utilisation pour l'hygiene buccale et procede d'hygiene buccale. |
US5330748A (en) | 1993-05-19 | 1994-07-19 | Church & Dwight Co., Inc. | Dentifrices containing zinc oxide particles |
US6015547A (en) | 1997-10-27 | 2000-01-18 | Church & Dwight Co., Inc. | Stable solution of zinc ions and bicarbonate and/or carbonate ions |
JP3719874B2 (ja) * | 1998-04-24 | 2005-11-24 | サンスター株式会社 | 口腔用組成物 |
US8802060B2 (en) | 2007-10-01 | 2014-08-12 | Colgate-Palmolive Company | Foamable fluoride oral care composition |
AU2008326037B2 (en) | 2007-11-09 | 2014-05-01 | The Procter & Gamble Company | Oral stannous compositions |
US9376722B2 (en) | 2008-02-08 | 2016-06-28 | Colgate-Palmolive Company | Oral care methods and systems |
EP2249786B1 (en) | 2008-02-08 | 2017-07-19 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
AR070356A1 (es) * | 2008-02-08 | 2010-03-31 | Colgate Palmolive Co | Producto para cuidado oral y metodos de uso del mismo |
CA2760227C (en) * | 2009-05-26 | 2015-05-05 | Colgate-Palmolive Company | Dentifrice composition |
CN105411869A (zh) | 2009-05-26 | 2016-03-23 | 高露洁-棕榄公司 | 洁齿剂组合物 |
CN103025337B (zh) | 2009-11-17 | 2014-10-15 | 特锐拉克斯有限公司 | Led电源的检测和控制 |
SG185627A1 (en) | 2010-06-23 | 2012-12-28 | Colgate Palmolive Co | Encapsulation of ingredients in lactose matrix to form active encapsulates |
ES2529216T3 (es) | 2010-06-23 | 2015-02-18 | Colgate-Palmolive Company | Composición oral terapéutica |
CN108078798A (zh) | 2012-12-05 | 2018-05-29 | 高露洁-棕榄公司 | 氟化物稳定的含锌组合物 |
KR20150094676A (ko) | 2012-12-06 | 2015-08-19 | 콜게이트-파아므올리브캄파니 | 아연 함유 조성물용 계면활성제 시스템 |
RU2642620C2 (ru) * | 2012-12-18 | 2018-01-25 | Колгейт-Палмолив Компани | Стабильные композиции, содержащие ион металла |
JP2016503036A (ja) | 2012-12-24 | 2016-02-01 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | オーラルケア組成物 |
CN104721226B (zh) | 2013-12-19 | 2019-12-24 | 高露洁-棕榄公司 | 口腔护理组合物 |
CN104721063B (zh) | 2013-12-19 | 2018-05-08 | 高露洁-棕榄公司 | 包含氧化锌和柠檬酸锌的洁齿剂组合物 |
CN107205895B (zh) | 2015-07-01 | 2021-11-05 | 高露洁-棕榄公司 | 口腔护理组合物及使用方法 |
MX2018003770A (es) | 2016-06-24 | 2018-06-18 | Colgate Palmolive Co | Composiciones para el cuidado bucal y metodos de uso. |
MX370965B (es) | 2016-06-24 | 2020-01-10 | Colgate Palmolive Co | Composiciones para el cuidado bucal y métodos de uso. |
US10617620B2 (en) | 2016-06-24 | 2020-04-14 | Colgate-Palmolive Company | Oral care compositions and methods of use |
US10058493B2 (en) | 2016-12-21 | 2018-08-28 | Colgate-Palmolive Company | Oral care compositions and methods of use |
-
2013
- 2013-12-19 CN CN201310701692.8A patent/CN104721063B/zh active Active
-
2014
- 2014-12-17 TW TW103143993A patent/TWI642446B/zh not_active IP Right Cessation
- 2014-12-17 TW TW106121003A patent/TW201811300A/zh unknown
- 2014-12-19 EP EP14824728.1A patent/EP3082725B1/en active Active
- 2014-12-19 WO PCT/US2014/071335 patent/WO2015095627A1/en active Application Filing
- 2014-12-19 AU AU2014364436A patent/AU2014364436B2/en active Active
- 2014-12-19 CA CA2927624A patent/CA2927624C/en active Active
- 2014-12-19 JP JP2016541263A patent/JP2017500331A/ja active Pending
- 2014-12-19 KR KR1020167014852A patent/KR20160093627A/ko not_active Application Discontinuation
- 2014-12-19 RU RU2016124159A patent/RU2649804C1/ru active
- 2014-12-19 MY MYPI2016702119A patent/MY161447A/en unknown
- 2014-12-19 MX MX2016007545A patent/MX367036B/es active IP Right Grant
- 2014-12-19 BR BR112016013496-6A patent/BR112016013496B1/pt active IP Right Grant
- 2014-12-19 AR ARP140104820A patent/AR098882A1/es unknown
- 2014-12-19 US US15/106,280 patent/US10342750B2/en active Active
-
2016
- 2016-05-23 IL IL245776A patent/IL245776A/en active IP Right Grant
- 2016-05-27 PH PH12016501006A patent/PH12016501006A1/en unknown
- 2016-06-16 CL CL2016001544A patent/CL2016001544A1/es unknown
-
2019
- 2019-05-17 US US16/414,847 patent/US11278477B2/en active Active
-
2022
- 2022-03-18 US US17/698,618 patent/US20220202668A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201231056A (en) * | 2010-12-21 | 2012-08-01 | Colgate Palmolive Co | Metal salt compositions |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4331561A1 (en) * | 2022-08-31 | 2024-03-06 | Unilever IP Holdings B.V. | Use of oral care composition |
Also Published As
Publication number | Publication date |
---|---|
CA2927624C (en) | 2017-09-19 |
JP2017500331A (ja) | 2017-01-05 |
PH12016501006B1 (en) | 2016-07-04 |
CA2927624A1 (en) | 2015-06-25 |
US11278477B2 (en) | 2022-03-22 |
CL2016001544A1 (es) | 2017-02-03 |
IL245776A (en) | 2016-11-30 |
US10342750B2 (en) | 2019-07-09 |
MY161447A (en) | 2017-04-12 |
EP3082725A1 (en) | 2016-10-26 |
PH12016501006A1 (en) | 2016-07-04 |
RU2649804C1 (ru) | 2018-04-04 |
US20160303010A1 (en) | 2016-10-20 |
MX367036B (es) | 2019-08-02 |
AR098882A1 (es) | 2016-06-22 |
EP3082725B1 (en) | 2019-05-15 |
AU2014364436B2 (en) | 2016-10-13 |
CN104721063B (zh) | 2018-05-08 |
US20190269586A1 (en) | 2019-09-05 |
WO2015095627A1 (en) | 2015-06-25 |
CN104721063A (zh) | 2015-06-24 |
TW201811300A (zh) | 2018-04-01 |
KR20160093627A (ko) | 2016-08-08 |
BR112016013496B1 (pt) | 2020-11-03 |
TW201609169A (zh) | 2016-03-16 |
MX2016007545A (es) | 2016-10-04 |
BR112016013496A2 (pt) | 2018-07-10 |
US20220202668A1 (en) | 2022-06-30 |
IL245776A0 (en) | 2016-07-31 |
AU2014364436A1 (en) | 2016-06-16 |
RU2016124159A (ru) | 2018-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI642446B (zh) | 包含氧化鋅和檸檬酸鋅之潔牙劑組成物 | |
JP5947810B2 (ja) | 金属塩組成物 | |
TWI715530B (zh) | 含矽石與檸檬酸鋅之口腔護理組成物 | |
RU2561587C2 (ru) | Композиции для ухода за полостью рта, устойчивые к микробному росту | |
AU2010354716A1 (en) | Oral care compositions resistant to microbial growth | |
EP4044996A1 (en) | Oral care composition | |
CA2317067A1 (en) | Antimicrobial peroxy acid oral care compositions and methods | |
JP5676014B2 (ja) | 抗菌剤としてのハロゲン化ビフェノール | |
JP2014526463A (ja) | 3,3’−ジアルキル−1,1’−ビフェニル−2,2’−ジオールまたは3,3’−ジアルケニル−1,1’−ビフェニル−2,2’−ジオール・ベースのオーラルケアおよびスキンケア組成物 | |
EP4044995B1 (en) | Oral care composition | |
CA3050693A1 (en) | Oral care composition and use and method for the prevention and control of plaque formation, bad breath, gingivitis, periodontal diseases and/or dental caries |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |